Answers to the questions practitioners most commonly ask about WMD.
Is WMD proliferation financing the same as terrorist financing under AML frameworks?
No. Although both are forms of financial crime addressed within counter-financing regimes, proliferation financing (PF) and terrorist financing (TF) are distinct concepts. Proliferation financing generally refers to the provision of funds or financial services used, in whole or in part, for the manufacture, acquisition, development, export, transshipment, or use of weapons of mass destruction and their means of delivery, in contravention of applicable laws or, where relevant, UN Security Council resolutions. Terrorist financing concerns the funding of terrorist acts, organizations, or individual terrorists. The FATF Recommendations address these as separate (though related) obligations, and obliged entities typically must assess and mitigate PF risk distinctly from TF risk. Treating them as interchangeable can lead to gaps in controls, because the typologies, sanctions regimes, and evasion techniques often differ.
Does a screening match against a proliferation-related sanctions list mean a customer is financing WMD?
No. A screening alert or a potential match against a sanctions or watchlist is an indicator that warrants review, not evidence of wrongdoing. Matches may be false positives arising from similar names, incomplete data, or coincidental attributes, and even a true match generally establishes only that a person or entity is designated, not that a specific transaction constitutes proliferation financing. Designation and criminal culpability are separate questions determined under different legal standards. The compliance function's role is to detect, review, escalate, and where required freeze or report, in line with the applicable sanctions regime; it is not to adjudicate guilt. Confirmation of any legal consequence rests with the relevant authorities and legal processes.
Which sanctions lists and instruments should firms screen against for WMD proliferation risk?
Screening scope depends on the jurisdictions to which a firm is subject. Many programs incorporate designations issued under UN Security Council resolutions addressing proliferation, alongside national or regional measures, for example, lists maintained by relevant authorities in the US, the EU, and the UK, among others. Because designations and the underlying legal obligations diverge across regimes, firms typically screen against all lists applicable to their operations, customers, and transaction flows rather than assuming a single global list exists. The precise lists, listing criteria, and freezing obligations should be confirmed against the sanctions instruments in force in each applicable jurisdiction.
How should proliferation financing risk be incorporated into a firm's risk assessment?
Under the FATF standards, obliged entities and countries are generally expected to identify, assess, and understand proliferation financing risk and to take mitigating measures proportionate to that risk. In practice, firms may factor PF risk into their enterprise-wide and customer risk assessments by considering elements such as customer type and sector, geographic exposure to higher-risk jurisdictions, involvement in dual-use or controlled goods, complex ownership or intermediary structures, and trade-based indicators. How this is operationalized varies by regime and by the nature of the business, and the specific obligations should be confirmed against the applicable national implementation of the FATF Recommendations.
What red flags may indicate potential WMD proliferation financing?
Commonly cited indicators, which are illustrative and not exhaustive, and none of which alone proves wrongdoing, may include transactions involving dual-use or export-controlled goods; connections to jurisdictions subject to proliferation-related sanctions; use of front companies, complex ownership, or intermediaries that obscure the true parties; mismatches between a customer's stated business and its transaction activity; unusual routing, transshipment, or freight-forwarding patterns; and reluctance to provide end-user or end-use information. These typologies are aids to detection and should prompt further review and, where appropriate, escalation rather than automatic conclusions. Firms should treat them as risk signals to be assessed in context.
What are a firm's obligations when it identifies a suspected proliferation financing match or activity?
Obligations depend on the applicable regime, but they generally fall into two categories that should not be conflated: sanctions obligations and reporting obligations. Where a designated person or entity is involved, firms are typically required to apply asset-freezing measures and refrain from dealing, in accordance with the relevant sanctions instrument, often with notification to the competent authority. Separately, where activity gives rise to suspicion, firms may be required to file a suspicious activity or transaction report to the relevant financial intelligence unit, terminology and thresholds differ by jurisdiction. Firms should also be mindful of tipping-off restrictions where they apply. The exact steps, timeframes, and authorities involved should be confirmed against the sanctions and AML/CFT requirements in force in each applicable jurisdiction.